Theratechnologies Inc THTX
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 45.98M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 58.71
- Price/Sales
- 1.98
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 105
- Website
- https://www.theratech.com
Valuation
|
Metric
|
THTX
|
|---|---|
Price/Earnings (Normalized) | 58.71 |
Price/Book Value | — |
Price/Sales | 1.98 |
Price/Cash Flow | 19.26 |
Price/Earnings
THTX
Financial Strength
|
Metric
|
THTX
|
|---|---|
Quick Ratio | 0.54 |
Current Ratio | 0.84 |
Interest Coverage | −0.04 |
Quick Ratio
THTX
Profitability
|
Metric
|
THTX
|
|---|---|
Return on Assets (Normalized) | 3.26% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 27.53% |
Return on Assets
THTX
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|sH&GXX | LOCK|F<J> | $142B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Z%c?Fm$ | LOCK|tb>@ | $96B | |||
| Moderna Inc
MRNA
| LOCK|HYRvKN | LOCK|<^ | $89B | |||
| argenx SE ADR
ARGX
| LOCK|%<jd## | LOCK|GL | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|T#@TxP | LOCK|kFr | $43B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|n<J!ChsL | LOCK|!&%< | $30B | |||
| Incyte Corp
INCY
| LOCK|?<$$JQ& | LOCK|?m | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|@^X@<&> | LOCK|J@ | $22B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|##?@@q | LOCK|nJgP< | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|$hs$&# | LOCK|^lh | $15B |
United States